Jim Cramer Shed Light on These 9 Stocks

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 80

When a caller asked Cramer about Pfizer Inc. (NYSE:PFE), he said:

“It’s too low to sell. That’s all I can say. I can’t recommend it. I just don’t want you to sell it if you have it. Let the dividend do its job and then maybe we get some good news on the Seagen acquisition.”

Pfizer (NYSE:PFE) focuses on the discovery, development, production, and distribution of biopharmaceuticals, covering diverse therapeutic areas such as cardiovascular health, infectious diseases, oncology, immunology, and vaccines, including treatments for chronic conditions, cancer, and COVID-19. In November 2024, while discussing drug stocks, Cramer talked about Pfizer and said:

“Pfizer, which picked up some potentially revolutionary cancer therapies from Seagen, is now trading at nine times earnings, 6.5% yield, for heaven’s sake. Although, it has a vaccine business and it calls vaccines, and I quote, ‘one of the greatest public health advancements of all time’… Still, anything good there, it could fly.”

While we acknowledge the potential of Pfizer Inc. (NYSE:PFE) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure: None. This article was originally published at Insider Monkey.